Daria Arbogast

1.5k total citations
9 papers, 1.2k citations indexed

About

Daria Arbogast is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Daria Arbogast has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Daria Arbogast's work include Thyroid Cancer Diagnosis and Treatment (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer-related Molecular Pathways (2 papers). Daria Arbogast is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer-related Molecular Pathways (2 papers). Daria Arbogast collaborates with scholars based in United States. Daria Arbogast's co-authors include Manisha H. Shah, Minden Collamore, Michael R. Grever, Matthew D. Ringel, Richard T. Kloos, Michael V. Knopp, Lai Wei, Nathan C. Hall, Jiachao Liang and James R. Wright and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Daria Arbogast

9 papers receiving 1.1k citations

Peers

Daria Arbogast

EDM

ONCOL

MB

GENET

PRM

Ronald A. Ghossein United States

Kanchan Puttaswamy United States

Matti L. Gild Australia

Manuela Motta Italy

Bruno Torchio Italy

Venessa Tsang Australia

T Brown United States

Ning Qu China

Jan Włoch Poland

Agnieszka Czarniecka Poland

Ronald A. Ghossein United States

Daria Arbogast

686 ×1.0

EDM

288 ×0.6

ONCOL

267 ×0.7

MB

141 ×0.9

GENET

130 ×0.9

PRM

Citations per year, relative to Daria Arbogast Daria Arbogast (= 1×) peers Ronald A. Ghossein

Countries citing papers authored by Daria Arbogast

Since Specialization

Citations

This map shows the geographic impact of Daria Arbogast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daria Arbogast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daria Arbogast more than expected).

Fields of papers citing papers by Daria Arbogast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daria Arbogast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daria Arbogast. The network helps show where Daria Arbogast may publish in the future.

Co-authorship network of co-authors of Daria Arbogast

This figure shows the co-authorship network connecting the top 25 collaborators of Daria Arbogast. A scholar is included among the top collaborators of Daria Arbogast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daria Arbogast. Daria Arbogast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Zhao, Weiqiang, et al.. (2011). Unusual metastases of gastrointestinal stromal tumor and genotypic correlates: Case report and review of the literature.. PubMed. 2(1). 45–9. 21 indexed citations

2.

Ramaswamy, Bhuvaneswari, Mitch A. Phelps, Robert A. Baiocchi, et al.. (2010). A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors. Investigational New Drugs. 30(2). 629–638. 24 indexed citations

3.

Lam, Elaine T., Matthew D. Ringel, Richard T. Kloos, et al.. (2010). Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer. Journal of Clinical Oncology. 28(14). 2323–2330. 288 indexed citations

4.

Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology. 27(10). 1675–1684. 430 indexed citations

5.

Woyach, Jennifer A., Richard T. Kloos, Matthew D. Ringel, et al.. (2008). Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 94(1). 164–170. 129 indexed citations

6.

Mrózek, Ewa, Richard T. Kloos, Matthew D. Ringel, et al.. (2006). Phase II Study of Celecoxib in Metastatic Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2201–2204. 43 indexed citations

7.

Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2006). Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43–9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study. Journal of Clinical Oncology. 24(18_suppl). 5534–5534. 26 indexed citations

8.

Shah, Manisha H., Philip F. Binkley, Kenneth K. Chan, et al.. (2006). Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors. Clinical Cancer Research. 12(13). 3997–4003. 190 indexed citations

9.

Arbogast, Daria. (2002). Enteral Feedings With Comfort and Safety. Clinical journal of oncology nursing. 6(5). 275–280. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact